A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HSCT / hematopoietic stem cell transplantation

[Related PubMed/MEDLINE]
Total Number of Papers: 7362
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HSCT  (>> Co-occurring Abbreviation)
Long Form:   hematopoietic stem cell transplantation
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 "Mini" bank of only 8 donors supplies CMV-directed T cells to diverse recipients. CMV, CMVSTs
2019 3D Age-Specific Mortality Trajectory: A Survival Analysis Protocol. MLE
2019 A Case of T-Cell Large Granular Lymphocytic Leukemia and Renal Immunoglobulin Heavy Chain Amyloidosis. T-LGL
2019 A Chinese DADA2 patient: report of two novel mutations and successful HSCT. CECR1, DADA2, IL-6, MRI
2019 A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoietic stem cell transplant. EMA, GMR, GMT, GVHD, H1N1, HAI, IST, SIIV, VMN
2019 A critical role of the Gas6-Mer axis in endothelial dysfunction contributing to TA-TMA associated with GVHD. aGVHD, ECs, Gas, GVHD, TA-TMA
2019 A general practitioner's guide to hematopoietic stem-cell transplantation. ---
2019 A mixed methods analysis of perceived cognitive impairment in hematopoietic stem cell transplant survivors. ---
2019 A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation. AKI, CysC, NGAL
10  2019 A population-based analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005 - 2016. HM, IFD
11  2019 A randomized controlled trial of problem-solving training (PST) for hematopoietic stem cell transplant (HSCT) patients: Effects on anxiety, depression, distress, coping and pain. CG, IG, PST
12  2019 A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation. CDAD
13  2019 A rare case of acquired immunodeficiency associated with myelodysplastic syndrome. MAC, MDS, RAG1, RIC, SNP, UPD
14  2019 A Retrospective Analysis of Antithrombin III Replacement Therapy for the Treatment of Hepatic Sinusoidal Obstruction Syndrome in Children Following Hematopoietic Stem Cell Transplantation. ATIII, SOS
15  2019 A Spectrum of Clinical Findings from ALPS to CVID: Several Novel LRBA Defects. ALPS, CVID, LRBA, NGS, PIDD, RTE, Th, WB, WES
16  2019 A survey of infectious diseases and vaccination uptake in long-term hematopoietic stem cell transplant survivors in Australia. cGVHD, NSW, VPD
17  2019 ABO Blood Type Incompatibility Is Not a Risk Factor of Outcomes for Acute Myeloid Leukemia (AML) Patients After Unmanipulated Haplo-identical Peripheral Blood Hematopoietic Stem Cell Transplantation. AML, CMV, EBV, GVHD, OS, PTLD, TRM
18  2019 Access to Hematopoietic Stem Cell Transplantation among Pediatric Patients with Acute Lymphoblastic Leukemia: A Population-Based Analysis. ALL, CI, OR
19  2019 Acquired partial lipodystrophy with metabolic disease in children following hematopoietic stem cell transplantation: a report of two cases and a review of the literature. ALD, APL, GVHD, HOMA-Rs, IGT, OGTT
20  2019 Acupressure to Reduce Treatment-Related Symptoms for Children With Cancer and Recipients of Hematopoietic Stem Cell Transplant: Protocol for a Randomized Controlled Trial. ACT-CC, RCT
21  2019 Acute kidney injury in hematopoietic stem cell transplantation. AKI, GVHD, TA-TMA, VOD
22  2019 ADCC can improve graft vs leukemia effect after T- and B-cell depleted haploidentical stem cell transplantation in pediatric B-lineage ALL. CI
23  2019 Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial. CTCAE, GVHD, HLA
24  2019 Adoptive T Cell Therapy Strategies for Viral Infections in Patients Receiving Haematopoietic Stem Cell Transplantation. GVHD
25  2019 Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005-2015. ---
26  2019 Adverse Effects of Virus-Specific T-Cell Therapy: An Integrative Review. GVHD, VST
27  2019 Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis. GVHD, TRM
28  2019 Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients. LL, NHL, NRM, OS, PR
29  2019 Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease. SCD
30  2019 Allogeneic Hematopoietic Stem Cell Transplantation for Myeloma: Time for an Obituary or Not Just Yet! RIC, TRM
31  2019 Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP. ALL, HR, MUD, SI
32  2019 Allogeneic hematopoietic stem cell transplantation in advanced stage mycosis fungoides and Sezary syndrome: a concise review. CTCL
33  2019 Allogeneic hematopoietic stem cell transplantation in r/r Hodgkin lymphoma after treatment with checkpoint inhibitors: Feasibility and safety. CPIs
34  2019 Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning for adult cerebral X-linked adrenoleukodystrophy. ACALD
35  2019 Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties. ADs, EBMT, GVHD, NRM, OS, PFS
36  2019 Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions. EC
37  2019 Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults. ALL, AYA, CI, OS, TRM
38  2019 Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell Lymphoma. allo, auto, OS, PFS, PMBCL
39  2019 Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders. GVHD
40  2019 Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years. CI
41  2019 alphabeta T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation without Antithymocyte Globulin in Children with Chemorefractory Acute Myelogenous Leukemia. AML, GVHD
42  2019 Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease. aGVHD
43  2019 Amlodipine and calcineurin inhibitor-induced nephrotoxicity following allogeneic hematopoietic stem cell transplant. AKI, CCBs, CI, CNI, CrCl, HR
44  2019 An Explorative Study of Qualities in Interactive Processes with Children and Their Parents in Music Therapy during and after Pediatric Hematopoietic Stem Cell Transplantation. ---
45  2019 An injectable bone marrow-like scaffold enhances T cell immunity after hematopoietic stem cell transplantation. BMC
46  2019 An overview of letermovir: a cytomegalovirus prophylactic option. HCMV, HHV-5, LTV
47  2019 An unusual complication of sacral nerve root injury following bone marrow harvesting: a case report. EMG, MRI, NCS, PSIS, VAS
48  2019 Anthracycline-Induced Cardiotoxicity in Acute Myeloid Leukemia Patients Who Undergo Allogeneic Hematopoietic Stem Cell Transplantation. AML
49  2019 Anti-GD2 antibody-containing immunotherapy postconsolidation therapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation. CI, GM-CSF, HDCT, HR
50  2019 Antithymocyte globulin improves GVHD-free and relapse-free survival in unrelated hematopoietic stem cell transplantation. ATG, GRFS, GVHD, IST, OS, TRM
51  2019 Anxiety and Depression of the Patients with Hematological Malignancies during Hospitalization for Hematopoietic Stem Cell Transplantation. ---
52  2019 Application of "primed" Mesenchymal Stromal Cells in hematopoietic stem cell transplantation: Current status and Future prospects. MSCs
53  2019 Application of high-throughput next-generation sequencing for HLA typing of DNA extracted from postprocessing cord blood units. ---
54  2019 Application of stem cell transplantation in autoimmune diseases. ---
55  2019 Applying host disease status biomarkers to therapeutic response monitoring in invasive aspergillosis patients. AL, ANXA1, CRP, Hp, IA
56  2019 Approach to the Adult Acute Lymphoblastic Leukemia Patient. ALL, Ph, TKI, WBC
57  2019 Arrhythmias in Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-analysis. CI, OR
58  2019 Assessing the efficacy of an ambulatory peripheral blood hematopoietic stem cell transplant program using reduced intensity conditioning in a low-middle-income country. DFS, OS, RIC, TRM
59  2019 Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome. SOS
60  2019 Association between chronic bacterial airway infection and prognosis of bronchiolitis obliterans syndrome after hematopoietic cell transplantation. BOS, CAI
61  2019 Association between single nucleotide polymorphisms within HLA region and disease relapse for patients with hematopoietic stem cell transplantation. ALL, AML, HLA, LTA, RING1, SNPs
62  2019 Association of Epstein‑Barr virus infection with allogeneic hematopoietic stem cell transplantation in patients in Portugal. EBV
63  2019 Association of Outcomes and Socioeconomic Status in Mexican Patients Undergoing Allogeneic Stem Cell Transplantation. NGOs, SES
64  2019 Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia. ALDH2, AML, BMF, FA, MDS, RAEB
65  2019 Autoimmune hemolytic anemia and immune thrombocytopenia following hematopoietic stem cell transplant: A critical review of the literature. AIC
66  2019 Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE). ADWP, AHSCT, JACIE, MS
67  2019 Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Sclerosis. CNS, MS
68  2019 Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica. AQP4-IgG, NMOSD, SLE
69  2019 Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study. AEs, CD, SAEs
70  2019 B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children. ---
71  2019 Bacteremia in pediatric patients with hematopoietic stem cell transplantation. ---
72  2019 Biological variation of peripheral blood T-lymphocytes. AIDS, ANOVA, BV, CV, EFLM
73  2019 Biomarkers for Early Complications After Hematopoietic Stem Cell Transplantation. ---
74  2019 Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia. ALL
75  2019 Blockade of plasminogen activator inhibitor-1 empties bone marrow niche sufficient for donor hematopoietic stem cell engraftment without myeloablative conditioning. BM, PAI-1
76  2019 Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT. AML, BM, CR, IR
77  2019 Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis. BM, DFS, GVHD, OS, PB, PTCy
78  2019 Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma. cHL, FDG-PET, PFS, R/R
79  2019 Brincidofovir as a Salvage Therapy in Controlling Adenoviremia in Pediatric Recipients of Hematopoietic Stem Cell Transplant. BCV
80  2019 Bronchoalveolar lavage with pediatric flexible fibreoptic bronchoscope in pediatric haematopoietic stem cell transplant patients: Nursing considerations for operative complications. BAL, FB
81  2019 Bronchoscopic features, associations, and outcomes of organizing pneumonia following allogeneic hematopoietic stem cell transplantation. BAL, OP, URI
82  2019 Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group. CI, DIPSS, FB, HR, NRM, OS, PFS
83  2019 Cardiac involvement in beta-thalassaemia: current treatment strategies. ---
84  2019 Caring Process in Hematopoietic Stem Cell Transplantation: A Grounded Theory Study. ---
85  2019 Cause of pleuroparenchymal fibroelastosis following allogeneic hematopoietic stem cell transplantation. BO, cGVHD, LONIPCs, PPFE
86  2019 CD150highTreg cells may attenuate graft versus host disease and intestinal cell apoptosis after hematopoietic stem cell transplantation. GVHD, Treg cells
87  2019 CD25 deficiency: A new conformational mutation prevents the receptor expression on cell surface. ---
88  2019 CD3+/CD19+ Depleted Matched and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplant with Targeted T Cell Addback Is Associated with Excellent Outcomes in Pediatric Patients with Nonmalignant Hematologic Disorders. GVHD, MMUD, MUD, NMHD
89  2019 Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome. CVD
90  2019 Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment impacting outcomes. BSI, CoNS, GNB, GPC, IEAT, MDR
91  2019 Characteristics of Japanese patients with X-linked adrenoleukodystrophy and concerns of their families from the 1st registry system. X-ALD
92  2019 Characterization of reemergent anti-B red blood cell antibodies in a patient with recurrent acute myeloid leukemia with ABO-incompatible allogeneic peripheral blood stem cell transplantation. RBCs
93  2019 Chronic Cholangiopathy Associated with Primary Immune Deficiencies Can Be Resolved by Effective Hematopoietic Stem Cell Transplantation. PIDs
94  2019 Clearance of Hematologic Malignancies by Allogeneic Cytokine-Induced Killer Cell or Donor Lymphocyte Infusions. CIK, CR, DLI
95  2019 Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT. CV, IWG, TA-TMA
96  2019 Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance. HCMV, LMV, MBV
97  2019 Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation. DF, rhTM, SOS
98  2019 Clinical Features and HSCT Outcome for SCID in Turkey. Ig, MMRD, MUD, NBS, SCID
99  2019 Clinical Features of Chronic Graft-Versus-Host Disease Following Haploidentical Transplantation Combined with Infusion of a Cord Blood. cGVHD, CI, GOS, NIH
100  2019 Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 days. C-PC, CCIs, CIs, PCs, PI-PC